New Delhi, Dec 8 (PTI) Zydus Pharmaceuticals (USA) Inchas received final approval from the US health regulator tomarket Clozapine tablets, used in treatment of severeschizophrenia.
The company has got final approval from the US Food andDrug Administration (USFDA) to market the drug in thestrengths of 25 mg, 50 mg, 100 mg and 200 mg, Zydus Cadilasaid in a BSE filing.
The drug will be produced at the group's formulationsmanufacturing facility at SEZ, Ahmedabad.
The Zydus group has more than 175 approvals and so farfiled over 310 abbreviated new drug applications (ANDAs) sinceit started filings in 2003-04.
Zydus Pharmaceuticals Inc is a wholly-owned subsidiary ofCadila Healthcare Ltd.
Shares of Cadila Healthcare, the listed entity of thegroup, were up 0.41 per cent at Rs 418.80 per scrip on BSEtoday. PTI SVKANU.
This is unedited, unformatted feed from the Press Trust of India wire.